Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score

Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes

(2015) A. C. Cheung et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia

(2015) Kenichi Hosonuma et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid

(2015) Gideon M. Hirschfield et al.   GASTROENTEROLOGY

Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

(2015) Willem J. Lammers et al.   GASTROENTEROLOGY

Fibrates and cholestasis

(2015) Nisanne S. Ghonem et al.   HEPATOLOGY

The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis

(2015) Marco Carbone et al.   HEPATOLOGY

Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysis

(2015) Alla Y. Grigorian et al.   Clinics and Research in Hepatology and Gastroenterology

Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

(2014) Willem J. Lammers et al.   GASTROENTEROLOGY

The New Epidemiology of Primary Biliary Cirrhosis

(2014) Laura Griffiths et al.   SEMINARS IN LIVER DISEASE

Fenofibrate-associated nephrotoxicity: A review of current evidence

(2013) R. L. Attridge et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Fenofibrate and the kidney: an overview

(2013) Michael S. Kostapanos et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy

(2012) Xiao Feng HAN et al.   Journal of Digestive Diseases

Primary biliary cirrhosis and bile acids

(2012) Christophe Corpechot   Clinics and Research in Hepatology and Gastroenterology

Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study

(2011) R.-D. Ting et al.   DIABETES CARE

Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity

(2011) Rebecca L. Attridge et al.   Journal of Clinical Lipidology

Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome

(2011) Christophe Corpechot et al.   JOURNAL OF HEPATOLOGY

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

(2010) C. Levy et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis

(2010) Teru Kumagi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Primary biliary cirrhosis

(2009) Keith D. Lindor et al.   HEPATOLOGY

Ursodeoxycholic acid in primary biliary cirrhosis: Reply

(2009) Ulrich Beuers et al.   JOURNAL OF HEPATOLOGY

Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

(2008) Lucy J. Walker et al.   HEPATOLOGY

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

(2008) Christophe Corpechot et al.   HEPATOLOGY